Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.07B | 14.46B | 11.93B | 8.72B | 5.37B | Gross Profit |
9.84B | 9.51B | 7.34B | 5.15B | 2.52B | EBIT |
8.08B | 8.07B | 6.06B | 4.11B | 1.72B | EBITDA |
8.84B | 8.97B | 6.78B | 4.84B | 2.35B | Net Income Common Stockholders |
4.93B | 5.01B | 3.90B | 2.86B | 1.09B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.66B | 2.58B | 3.34B | 5.99B | 2.96B | Total Assets |
27.23B | 25.24B | 23.07B | 22.89B | 18.14B | Total Debt |
11.46B | 10.88B | 10.39B | 7.92B | 4.71B | Net Debt |
9.80B | 8.30B | 7.06B | 1.93B | 1.75B | Total Liabilities |
16.69B | 15.40B | 14.52B | 11.65B | 7.31B | Stockholders Equity |
10.38B | 9.67B | 8.37B | 11.06B | 10.65B |
Cash Flow | Free Cash Flow | |||
5.88B | 5.93B | 2.08B | 2.52B | -138.16M | Operating Cash Flow |
6.20B | 6.33B | 4.99B | 4.45B | 1.30B | Investing Cash Flow |
-2.51B | -2.79B | -2.75B | -1.79B | -1.32B | Financing Cash Flow |
-4.66B | -4.30B | -4.88B | 292.27M | -528.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $3.92B | 14.58 | 50.41% | 5.12% | 0.83% | -4.88% | |
76 Outperform | $8.61B | 11.59 | 28.24% | 2.02% | 17.41% | 28.94% | |
76 Outperform | $483.71B | 38.20 | 191.95% | 0.52% | 12.07% | 17.27% | |
70 Outperform | $9.64B | 20.65 | 42.32% | 3.70% | -2.03% | -11.39% | |
68 Neutral | $41.36B | 25.64 | -33.93% | 1.50% | 0.37% | 19.87% | |
62 Neutral | $8.08B | 13.63 | 3.82% | 3.13% | 3.58% | -14.35% |